RecruitingNot ApplicableNCT07059689

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

High Flow Nasal Cannula vs. Non-Invasive Ventilation in Post-Extubation Pediatric Cardiac Surgery Patients: A Randomized Controlled Trial

Sponsor

Indonesia University

Enrollment

114 participants

Start Date

Jun 5, 2025

Study Type

INTERVENTIONAL

Conditions

Heart Defects, Congenital Extubation Respiration, Artificial Intensive Care Units, Pediatric

Summary

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called High Flow Nasal Cannula (HFNC) and a medical device called Non-Invasive Ventilation (NIV) for people with extubation, heart defects, congenital, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHigh Flow Nasal Cannula (HFNC)

Participants in this arm will receive High Flow Nasal Cannula therapy using the Airvo™3 Nasal High Flow System immediately after planned extubation following cardiac surgery

DEVICENon-Invasive Ventilation (NIV)

Participants in this arm will receive Non-Invasive Ventilation (NIV) immediately after planned extubation following cardiac surgery. NIV will be delivered using standard ICU ventilator settings, with parameters tailored to each patient's clinical condition